Hepion Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
This page contains a questions and answers table for Hepion Pharmaceuticals Inc. Comprehensive Sustainability analysis of Hepion Pharmaceuticals Inc can be reached by registering for free. This Sustainability rating for Hepion Pharmaceuticals Inc represents the company's reporting of the UN Sustainable Development Goals.
Hepion Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.7, social score of 3.2 and governance score of 4.0.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1234 | Quanterix Corp | 3.4 | Medium |
| 1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
| 1253 | Hepion Pharmaceuticals Inc | 3.3 | Medium |
| 1253 | Calithera Biosciences Inc | 3.3 | Medium |
| 1253 | Cara Therapeutics Inc | 3.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Hepion Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Hepion Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Hepion Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Hepion Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Hepion Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Hepion Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Hepion Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH), as well as in nonclinical studies to reduce liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH, and has demonstrated antiviral activities towards hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.